• AMPK-PGC-1α-SOD Axis Protects Against Doxorubicin Cardiotoxi

  2026-06-25

  This study demonstrates that hydroethanolic extract of Cirsium setidens (CSE) mitigates doxorubicin-induced cardiotoxicity by activating the AMPK-PGC-1α-NRF1 signaling pathway, leading to enhanced mitochondrial protection and reduced cardiomyocyte apoptosis. The mechanistic dissection highlights new avenues for cardioprotective strategies in chemotherapy contexts, with implications for metabolic and oxidative stress-related cardiovascular research.

• Cefodizime in Antimicrobial Resistance Surveillance: Novel I

  2026-06-24

  Explore Cefodizime, a third-generation cephalosporin antibiotic, through the lens of antimicrobial resistance surveillance and translational research. This article offers a unique, data-driven analysis for researchers seeking to optimize resistance assays and infection models.

• Dopamine Transporter Imaging for Assessing Neuron Maturation

  2026-06-23

  Goggi et al. (2020) establish dopamine transporter (DAT) neuroimaging as a precise, non-invasive method to monitor the maturation and function of transplanted dopaminergic neurons derived from human embryonic stem cells in a preclinical Parkinson’s disease model. The study’s methodological rigor and imaging-histology correlation advance translational strategies for cell therapy evaluation.

• Amitriptyline HCl: Neurotransmitter Modulation and Research

  2026-06-23

  Amitriptyline HCl is a high-purity tricyclic compound used for precise neurotransmitter receptor modulation in neuropharmacology research. Its potent inhibition of serotonin and norepinephrine receptors, verified stability, and solubility profile make it a benchmark tool for mechanistic studies of mood and neurodegenerative disorders.

• iRhom2 Regulates Odorant Receptor Adaptation in Olfactory Ne

  2026-06-22

  This study uncovers a unique role for iRhom2 in olfactory sensory neurons, linking it to odorant receptor regulation and activity-dependent adaptation. Through transcriptomic and functional assays, the authors demonstrate that iRhom2 mediates feedback mechanisms controlling olfactory receptor expression, offering new insights into sensory plasticity.

• Protoporphyrin IX: Precision Tool for Photodynamic Cancer Re

  2026-06-22

  Explore how Protoporphyrin IX, a key photodynamic compound, enables high-fidelity cancer research and diagnostic innovation. This article uniquely bridges mechanistic insight with practical assay guidance for advanced oncology workflows.

• Y-27632: Selective ROCK Inhibitor for Cytoskeletal Modulatio

  2026-06-21

  Y-27632 is a potent, selective ROCK inhibitor widely used for disrupting actin stress fibers and modulating cytoskeletal dynamics in cell biology research. Its high specificity and reproducibility make it crucial for studies of ROCK signaling pathways, especially in cancer biology and mechanotransduction. APExBIO supplies Y-27632 (SKU B1293) as a high-quality research reagent.

• ML133 HCl: Precision Potassium Channel Inhibitor Workflows

  2026-06-20

  ML133 HCl enables highly selective inhibition of Kir2.1 channels, unlocking robust and reproducible research in pulmonary artery smooth muscle cell proliferation and migration. This guide delivers actionable workflow enhancements, troubleshooting strategies, and practical insights for cardiovascular ion channel research.

• EZ Cap™ Firefly Luciferase mRNA: Cap 1 Reporter for Robust A

  2026-06-19

  EZ Cap™ Firefly Luciferase mRNA is a synthetic, Cap 1-capped transcript enabling superior bioluminescent reporter assays and high-efficiency mRNA delivery. It offers enhanced translation, stability, and reproducibility for gene regulation and in vivo molecular imaging in mammalian systems.

• AMPK Restrains Autophagy via ULK1 Inhibition in Energy Stres

  2026-06-19

  This study overturns the prevailing model by demonstrating that AMPK activation suppresses, rather than induces, autophagy through direct inhibition of ULK1 during cellular energy stress. These insights refine our understanding of metabolic stress responses and provide a more nuanced framework for autophagy research in disease models.

• Oral mSWI/SNF PROTACs and ABCB1-Mediated Resistance in Prost

  2026-06-18

  This study introduces AU-24118, the first orally bioavailable PROTAC degrader of mSWI/SNF ATPases, achieving marked antitumor efficacy in preclinical prostate cancer models. Critically, the work delineates two acquired resistance mechanisms—SMARCA4 mutations and ABCB1 (P-glycoprotein) overexpression—and demonstrates that ABCB1 inhibition by zosuquidar restores drug sensitivity, guiding future strategies for addressing multidrug resistance in targeted cancer therapies.

• Chrysin Sensitizes RCC to Sunitinib via Ferroptosis and PI3K

  2026-06-18

  The referenced study demonstrates that chrysin, a natural flavonoid, enhances sunitinib sensitivity in renal cell carcinoma by inducing ferroptosis through downregulation of the PI3K/Akt/GPX4 pathway. This mechanistic insight offers a promising strategy to overcome drug resistance in RCC and supports further translational research on combination therapies.

• Jasplakinolide: Precision Actin Modulation & Assay Decisions

  2026-06-17

  Explore how Jasplakinolide, a potent actin polymerization inducer, enables high-fidelity cytoskeletal research and informed assay selection. This guide bridges molecular mechanism with practical protocol insights, offering unique comparative depth for cell biology investigators.

• PHF2 Regulates Neuroinflammation in Alzheimer’s Disease Mode

  2026-06-17

  This study identifies histone demethylase PHF2 as a pivotal regulator of inflammatory gene expression in Alzheimer’s disease (AD). Through human, mouse, and cellular models, the research highlights PHF2’s upregulation in AD and demonstrates that reducing PHF2 mitigates neuroinflammatory signaling and cognitive deficits, suggesting a novel epigenetic intervention point.

• Q-VD(OMe)-OPh: Precision Caspase Inhibition for Translationa

  2026-06-16

  This thought-leadership article explores how Q-VD(OMe)-OPh, a potent broad-spectrum pan-caspase inhibitor, redefines apoptosis research and empowers translational breakthroughs across oncology, neuroprotection, and cell differentiation. By weaving together mechanistic insights, data-driven protocol guidance, and strategic perspectives, the piece highlights the compound's competitive edge and translational relevance, referencing pivotal studies and highlighting new opportunities for advanced experimental design.

459 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page